• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ITRM

ITRM

Iterum Therapeutics plc

NASDAQHealthcareBiotechnologyIE

USD0.03

-0.00 (-10.98%)

Company Profile

CEO

Corey N. Fishman

IPO Date

2018-05-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

IE

Market Metrics

Open

$0.04

Prev. Close

$0.03

Day Low

$0.03

Day High

$0.05

52W Low

$0.03

52W High

$1.42

Market Cap

$0.00B

Volume

49.30M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

13.9%

Avg Negative

46.3%

Avg Neutral

39.9%

News Feed

Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks Investment Research·7/29/2021·↓ negative

ITRM Stock Falls Over 40% Pre-Market: Why It Happened

Pulse2·7/26/2021·↓ negative

Iterum Therapeutics Stock Plunges After FDA Rejects Its Sulopenem Application

Benzinga·7/26/2021·↑ positive

Iterum Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Oral Sulopenem

GlobeNewsWire·7/26/2021·↑ positive

Top Penny Stocks to Buy Next Week? 3 to Watch In Summer 2021

PennyStocks·7/16/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iterum Therapeutics plc (ITRM)

PRNewsWire·7/7/2021·↓ negative

Trending Reddit Penny Stocks to Buy Now? Take a Look At These 7

PennyStocks·7/6/2021·↓ negative

Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy

Seeking Alpha·7/5/2021·↓ negative

Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter

Benzinga·7/2/2021·↓ negative

Why Iterum Therapeutics Stock Is Crashing Today

The Motley Fool·7/2/2021·↓ negative